Evidence map›Paper›PMID 42517958›Full record

ArticleThe Journal of membrane biology2026

Mechanistic Insights into Autoinhibition of the Human Flippase ATP8B1.

Michelle Juknaviciute Laursen, Mathilde Roth, Poul Nissen, Charlott Stock, Thibaud Dieudonné

Abstract read
In one paragraph

Article in The Journal of membrane biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Michelle Juknaviciute LaursenDANDRITE, Nordic EMBL Partnership for Molecular Medicine, Department of Molecular Biology and Genetics, Aarhus University, Aarhus, Denmark.ORCID http://orcid.org/0009-0008-2332-0230
Mathilde RothInstitute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Université Paris-Saclay, 91198, Gif-sur-Yvette, France.ORCID http://orcid.org/0009-0001-5241-3953
Poul NissenDANDRITE, Nordic EMBL Partnership for Molecular Medicine, Department of Molecular Biology and Genetics, Aarhus University, Aarhus, Denmark.ORCID http://orcid.org/0000-0003-0948-6628
Charlott StockDANDRITE, Nordic EMBL Partnership for Molecular Medicine, Department of Molecular Biology and Genetics, Aarhus University, Aarhus, Denmark. cs@mbg.au.dk.ORCID http://orcid.org/0000-0001-5471-3696
Thibaud DieudonnéInstitute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Université Paris-Saclay, 91198, Gif-sur-Yvette, France. thibaud.dieudonne@i2bc.paris-saclay.fr.ORCID http://orcid.org/0000-0001-6988-4121

Funding

Agence Nationale de la Recherche CPJ 24HR4277Carlsbergfondet CF23-1394French Ministry for Higher Education PhD fellowshipLundbeck Foundation R310-2018-3713Novo Nordisk Fonden NNF23OC0087232
6 · The paper itself

Abstract

P4-ATPases are lipid flippases that maintain membrane phospholipid asymmetry by transporting specific phospholipids from the exoplasmic to the cytosolic leaflet, an essential process for membrane integrity, trafficking and signaling. Several P4-ATPases are tightly regulated by autoinhibitory N- and C-terminal extensions, yet the molecular basis of this regulation remains incompletely understood. Here, we investigated the autoinhibition mechanism of the human flippase ATP8B1 using trans-inhibition assays with synthetic peptides derived from its C-terminal tail. Using purified C-terminally truncated ATP8B1-CDC50A, we systematically assessed the inhibitory properties of peptides corresponding to distinct segments of the C-terminus. We show that the distal disordered region of the C-terminal tail significantly contributes to autoinhibition, likely through transient interactions with the cytosolic domains. We further identify a critical interaction between R1228 in the C-terminal tail and E219 in the A-domain, whose disruption markedly reduces inhibitory potency. In addition, we demonstrate that a minimal peptide spanning residues 1216-1228, which bridges the A- and N-domains in the autoinhibited conformation, is sufficient to inhibit ATPase activity. Together, these results refine the molecular description of ATP8B1 autoinhibition, open the way for structure-based activation strategies and provide insight into conserved regulatory mechanisms among P4-ATPases.

Indexed as

Adenosine TriphosphatasesPhospholipid Transfer ProteinsHumansPeptidesProtein BindingProtein DomainsAdenosine TriphosphatasesATP8B1 protein, humanPeptidesPhospholipid Transfer ProteinsATP8B1AutoinhibitionFlippasesIntrahepatic cholestasisP4-ATPasePFIC1P-type ATPase

Identifiers

PMID42517958
PMCPMC13415658

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.